Home

Thermo Fisher Scientific (TMO)

516.57
-7.07 (-1.35%)

Thermo Fisher Scientific is a global leader in providing scientific instruments, reagents, and consumables, with a focus on advancing healthcare, life sciences, and laboratory workflows

The company supports a diverse range of customers, including researchers, clinical laboratories, and pharmaceutical companies, by offering innovative solutions that enable breakthroughs in areas such as diagnostics, drug development, and environmental analysis. With a commitment to quality and efficiency, Thermo Fisher Scientific plays a crucial role in enhancing productivity and scientific discovery across various disciplines while promoting better health outcomes worldwide.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close523.64
Open523.02
Bid514.00
Ask523.00
Day's Range512.46 - 524.85
52 Week Range493.30 - 627.88
Volume2,720,159
Market Cap203.23B
PE Ratio (TTM)31.25
EPS (TTM)16.5
Dividend & Yield1.560 (0.30%)
1 Month Average Volume2,005,725

News & Press Releases

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSERVTY) and the best and worst performers in the research tools & consumables industry.
Via StockStory · March 3, 2025
Trian Comments on Solventum’s Sale of its Purification & Filtration Business
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSESOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on Solventum’s recently announced sale of its Purification & Filtration business to Thermo Fisher Scientific Inc NYSE: TMONYSETMO)
By Trian Fund Management, L.P. · Via GlobeNewswire · February 26, 2025
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favorbenzinga.com
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.
Via Benzinga · February 25, 2025
Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billionbenzinga.com
Thermo Fisher will acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction portfolio with expected long-term growth.
Via Benzinga · February 25, 2025
Thermo Fisher Scientific Unusual Options Activitybenzinga.com
Via Benzinga · February 21, 2025
Looking Into Thermo Fisher Scientific's Recent Short Interestbenzinga.com
Via Benzinga · February 20, 2025
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · February 3, 2025
Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business
Thermo Fisher Scientific Inc. (NYSETMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive agreement with Solventum NYSE: SOLVNYSESOLV)
By Thermo Fisher Scientific Inc. · Via Business Wire · February 25, 2025
Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025
Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. (ET).
By Thermo Fisher Scientific Inc. · Via Business Wire · February 24, 2025
Thermo Fisher Scientific Increases Quarterly Dividend
Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on April 15, 2025, to shareholders of record as of March 14, 2025. This reflects an 10% increase over the previous dividend payment of $0.39.
By Thermo Fisher Scientific Inc. · Via Business Wire · February 19, 2025
Thermo Fisher Scientific Elects New Director to Board
Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12.
By Thermo Fisher Scientific Inc. · Via Business Wire · February 19, 2025
Analyst Expectations For Thermo Fisher Scientific's Futurebenzinga.com
Via Benzinga · January 31, 2025
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Yearsbenzinga.com
Via Benzinga · February 18, 2025
3 Healthcare Stocks Skating on Thin Ice
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024. This has capped returns as the industry’s six-month gain of 1.2% has lagged the S&P 500’s 12.8% climb.
Via StockStory · February 12, 2025
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · February 10, 2025
Gapping S&P500 stocks in Monday's sessionchartmill.com
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Via Chartmill · February 10, 2025
Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO
Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO designed to increase access to renewable electricity across the pharmaceutical and healthcare supply chains. The Lorca solar project is expected to be operational in early 2026 and includes a cohort of three partners from the pharmaceutical and healthcare sectors.
By Thermo Fisher Scientific Inc. · Via Business Wire · February 4, 2025
Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcriptfool.com
TMO earnings call for the period ending December 31, 2024.
Via The Motley Fool · January 30, 2025
Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates
Life sciences company Thermo Fisher (NYSETMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per share was 2.7% above analysts’ consensus estimates.
Via StockStory · January 30, 2025
Top S&P500 movers in Thursday's sessionchartmill.com
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.
Via Chartmill · January 30, 2025
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · January 30, 2025
Thermo Fisher Scientific Gaps Up, Nearing A Buy Point, On Strong Earnings Beatinvestors.com
Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter forecasts.
Via Investor's Business Daily · January 30, 2025
Thursday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.
Via Chartmill · January 30, 2025
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expandsbenzinga.com
Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.
Via Benzinga · January 30, 2025
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results
Thermo Fisher Scientific Inc. (NYSETMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2024.
By Thermo Fisher Scientific Inc. · Via Business Wire · January 30, 2025